Ken, Velasco V.
HRN: 21-23-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2022
MUPIROCIN 2%, 15G (TUBE)
04/10/2022
04/17/2022
TOPICAL
TID
TID
PUNCTURED WOUNDS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes